BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18203809)

  • 1. Physiological roles of semenogelin I and zinc in sperm motility and semen coagulation on ejaculation in humans.
    Yoshida K; Kawano N; Yoshiike M; Yoshida M; Iwamoto T; Morisawa M
    Mol Hum Reprod; 2008 Mar; 14(3):151-6. PubMed ID: 18203809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.
    Robert M; Gibbs BF; Jacobson E; Gagnon C
    Biochemistry; 1997 Apr; 36(13):3811-9. PubMed ID: 9092810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process.
    de Lamirande E; Yoshida K; Yoshiike TM; Iwamoto T; Gagnon C
    J Androl; 2001; 22(4):672-9. PubMed ID: 11451365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postejaculatory zinc redistribution and sperm senescence.
    Arver S
    J Trace Elem Electrolytes Health Dis; 1987 Sep; 1(1):45-8. PubMed ID: 2856564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term effects of human seminal plasma from whole semen and from different fractions of split ejaculate on motility of human ejaculated spermatozoa].
    Sanada S; Arai E; Ueda M; Ogura K; Yoshida O
    Hinyokika Kiyo; 1988 Nov; 34(11):1965-72. PubMed ID: 3242371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein.
    Robert M; Gagnon C
    Cell Mol Life Sci; 1999 Jun; 55(6-7):944-60. PubMed ID: 10412373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of a sperm motility inhibitor from boar seminal plasma.
    Iwamoto T; Tanaka H; Osada T; Shinagawa T; Osamura Y; Gagnon C
    Mol Reprod Dev; 1993 Dec; 36(4):475-81. PubMed ID: 8305210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin.
    Robert M; Gagnon C
    Biol Reprod; 1996 Oct; 55(4):813-21. PubMed ID: 8879494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sperm motility inhibitor from human seminal plasma: presence of a precursor molecule in seminal vesicle fluid and its molecular processing after ejaculation.
    Robert M; Gagnon C
    Int J Androl; 1994 Oct; 17(5):232-40. PubMed ID: 7698848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the coagulation-liquefaction property of human ejaculates and their volume, sperm count and motility.
    Mandal A; Bhattacharyya AK
    Clin Reprod Fertil; 1987 Dec; 5(6):367-71. PubMed ID: 3505831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of metal ions (Fe2+, Mn2+, Pb2+) on sperm motility and lipid peroxidation in human semen.
    Huang YL; Tseng WC; Lin TH
    J Toxicol Environ Health A; 2001 Feb; 62(4):259-67. PubMed ID: 11245395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sperm motility inhibitor from human seminal plasma: association with semen coagulum.
    Robert M; Gagnon C
    Hum Reprod; 1995 Aug; 10(8):2192-7. PubMed ID: 8567872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of prostatic- and seminal vesicle-secreted proteins involved in the gelation and liquefaction of human semen.
    Lilja H
    Scand J Clin Lab Invest Suppl; 1988; 191():13-20. PubMed ID: 2470129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous protein kinases A and C, but not endogenous prostasome-associated protein kinase, phosphorylate semenogelins I and II from human semen.
    Ek P; Malm J; Lilja H; Carlsson L; Ronquist G
    J Androl; 2002; 23(6):806-14. PubMed ID: 12399526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental studies of male infertility and zinc].
    Oka N; Matsumoto O; Kamidono S
    Hinyokika Kiyo; 1988 Jan; 34(1):1-10. PubMed ID: 3376788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origin of the human seminal plasma motility inhibitor within the reproductive tract.
    Luterman M; Iwamoto T; Gagnon C
    Int J Androl; 1991 Apr; 14(2):91-8. PubMed ID: 1869319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper in split and daily ejaculates.
    Valsa J; Gusani PH; Skandhan KP; Modi HT
    J Reprod Med; 1994 Sep; 39(9):725-8. PubMed ID: 7807487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dot-blot-immunoassay for semen identification using a polyclonal antibody against semenogelin, a powerful seminal marker.
    Sato I; Yoshiike M; Yamasaki T; Yoshida K; Takano S; Mukai T; Iwamoto T
    Forensic Sci Int; 2001 Oct; 122(1):27-34. PubMed ID: 11587862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seminal fluid concentration of ketoconazole and its effect on spermatozoa motility].
    Schramm P
    Z Hautkr; 1984 Feb; 59(3):173-4, 177-8. PubMed ID: 6326403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seminal plasma biochemistry. I. Preliminary report: a possible mechanism for the liquefaction of human seminal plasma and its relationship to spermatozoal motility.
    Daunter B; Hill R; Hennessey J; Mackay EV
    Andrologia; 1981; 13(2):131-41. PubMed ID: 7247044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.